Actively Recruiting
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
Led by Pack Health · Updated on 2025-04-20
100
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
Sponsors
P
Pack Health
Lead Sponsor
U
University of Washington
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will evaluate the feasibility of a digital health coaching program for adults with relapsed or refractory multiple myeloma (R/R MM). One hundred adults with R/R MM will be enrolled at The University of Washington. Individuals who agree to take part in the study and sign an informed consent will be enrolled in a 3-month digital health coaching program. The program will provide weekly phone calls plus the delivery of learning materials to text or email. Questionnaires and data from a wrist-worn activity tracker will be collected. Outcomes include treatment and symptom experience, quality of life, financial burden, and how confident people feel to manage their health. Information about your condition and treatment will be collected, along with how often you use services like the emergency room, for care. This data will provide a better understanding of how a person experiences their R/R MM.
CONDITIONS
Official Title
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or older
- Confirmed diagnosis of multiple myeloma by primary physician at study site
- Patients with concurrent AL amyloidosis are eligible
- Starting at least second line of multiple myeloma therapy at enrollment
- Must have been treated with at least one proteasome inhibitor or immunomodulatory drug
You will not qualify if you...
- Terminal illness with estimated survival of 6 months or less or receiving only comfort care
- Prior participation in Pack Health digital health coaching
- Insufficient English proficiency as assessed by physician
- No personal smartphone or device enabling text, email, or mobile app access
- Serious or unstable medical or psychiatric conditions interfering with safety or study compliance
- Enrolled in another therapeutic study for relapsed or refractory multiple myeloma that prevents participation in this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Washington
Seattle, Washington, United States, 98195
Actively Recruiting
Research Team
K
Kelly Brassil, PhD
CONTACT
J
Jennifer Loftis, DNP
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here